Drug Type Antibody |
Synonyms AMG 355 |
Target |
Action modulators |
Mechanism CCR8 modulators(C-C motif chemokine receptor 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Malignant Solid Neoplasm | Phase 1 | United States | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Japan | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Australia | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Canada | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | France | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Netherlands | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Poland | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Switzerland | 07 Mar 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Taiwan Province | 07 Mar 2024 |